Simtuza combination tablets, containing Darunavir ethanolate, cobicistat, emtricitabine, and tenofovir alafenamide fumarate, are a four-drug fixed-dose combination. This prescription medicine, manufactured by Janssen Pharmaceutical, is used to treat Human Immunodeficiency Virus-1 (HIV-1) infection in adults and children weighing at least 88 pounds. It is available as 1 tablet and has a YJ code of 6250118F1024.
Simtuza combination tablets
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).